The COVID-19 pandemic triggered massive volatility in the stock market, with increased instability in recent weeks as surging cases have led to a rush of people looking for tests. We've rounded up 9 stocks in companies that produce or sell COVID tests.
The best stocks depend on your portfolio and investment goals. While volatility can be ideal for day traders, long-term investors will want to look to stocks with steadier gains over time.
The top COVID-19 testing stocks included on this page all trade on the S&P 500, have an analyst recommendation of "Buy" or better and are sorted by year-to-date performance.
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.
Abbott Laboratories stock opened the day at $133.07 after a previous close of $132.99. The latest price was $133.26 (25-minute delay). Abbott Laboratories is listed on the NYSE, has a trailing 12-month revenue of around USD42.3 billion and employs 114,000 staff.
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions.
Quidel Corporation stock opened the day at $27.69 after a previous close of $28.03. The latest price was $27.65 (25-minute delay). Quidel Corporation is listed on the NASDAQ, has a trailing 12-month revenue of around USD$2.8 billion and employs 6,600 staff.
Cue Health Inc. operates as a healthcare technology company. It provides the Cue Health platform that offers individuals and healthcare providers convenient and personalized access to lab-quality diagnostic tests at home and at the point-of-care, as well as on-demand telehealth consultations and treatment options for a range of health and wellness needs.
Cue Health stock opened the day at $0.00 after a previous close of $0.00. The latest price was $0.00 (25-minute delay). Cue Health is listed on the NASDAQ, has a trailing 12-month revenue of around USD$56.2 million and employs 726 staff.
Lucira Health, Inc. , a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services.
Lucira Health stock opened the day at $0.00 after a previous close of $0.00. The latest price was $0.00 (25-minute delay). Lucira Health is listed on the NASDAQ, has a trailing 12-month revenue of around USD$212.1 million and employs 221 staff.
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U. S.
Walgreens Boots Alliance stock opened the day at $11.29 after a previous close of $11.31. The latest price was $11.35 (25-minute delay). Walgreens Boots Alliance is listed on the NASDAQ, has a trailing 12-month revenue of around USD$151.9 billion and employs 193,000 staff.
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services.
CVS Health stock opened the day at $66.37 after a previous close of $66.57. The latest price was $66.81 (25-minute delay). CVS Health is listed on the NYSE, has a trailing 12-month revenue of around USD$376.7 billion and employs 219,000 staff.
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab.
Agilent Technologies stock opened the day at $114.95 after a previous close of $115.56. The latest price was $116.13 (25-minute delay). Agilent Technologies is listed on the NYSE, has a trailing 12-month revenue of around USD$6.6 billion and employs 18,000 staff.
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health.
Hologic stock opened the day at $64.11 after a previous close of $64.48. The latest price was $64.43 (25-minute delay). Hologic is listed on the NASDAQ, has a trailing 12-month revenue of around USD$4 billion and employs 7,063 staff.
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services.
Laboratory Corporation of America stock opened the day at $260.70 after a previous close of $261.88. The latest price was $261.04 (25-minute delay). Laboratory Corporation of America is listed on the NYSE, has a trailing 12-month revenue of around USD$13.2 billion and employs 60,900 staff.
Check out Finder's picks for the best brokerage accounts
Compare top brokerage accounts and apps to help you maximize your investment.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Investing is more accessible than you may think. Here are five ways to start investing when you have little money to invest.
These are the stocks to buy when you don’t have much to spend.
Cash sweep accounts let you earn interest on your uninvested cash. Learn how they work and how to choose the best one here.
We review the Kalshi trading platform and explain how investors can use it as a hedge for their investments.
Market capitalization can help investors determine a company’s market value to predict growth, but there are some considerations to keep in mind.
Compare pros, cons, research tools and reviews for these two trading platforms.
Fractional shares are fractions of company shares. Sometimes they’re made by brokers to allow those with limited funds to get access to stocks.
SoFi Invest is a no-fee commissions platform with both active and automated investment accounts.
Webull is a broker with zero-commission trading and a suite of tools to help you invest.
A deep dive into the highlights and limitations of Robinhood.